CF PharmTech is a specialty pharmaceutical company that develops and manufactures inhalation products.
CF PharmTech was founded in 2007, it is a fully independent, dynamic, integrated, specialty pharmaceutical company focused on the development and manufacturing of products for the treatments of asthma, COPD and allergic rhinitis for the global market. Its mission is to develop high-quality and affordable medicine to help patients achieve effective management care for their respiratory diseases. The headquarters is located in the lakeside of the Caohu District of Suzhou, Jiangsu Province, with many very convenient transportation options available. It only takes thirty minutes by train to Shanghai and four hours by train to Beijing.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 1, 2020 | Series F | ¥360M | 4 | — | — | Detail |
Jan 1, 2020 | Series E | ¥630M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
GP M&A Fund | — | Series F |
CICC Qichen | — | Series F |
Passion Capital | — | Series F |
Watson Investment | — | Series F |
Finnova Capital | — | Series E |